Pomerantz LLP & Lewis Kahn
1 shared events · Importance 3 · Last updated May 09, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Pomerantz LLP: Pomerantz LLP has announced a class action lawsuit against MiNK Therapeutics, advising investors to contact them regarding potential securities fraud.
Lewis Kahn: Lewis Kahn, Managing Partner at Kahn Swick & Foti, is a key contact for investors interested in joining the class action lawsuit against MiNK Therapeutics.
Apr 01, 2026 · 83 articles
NEWSDESK
Explore this relationship live
Track how Pomerantz LLP and Lewis Kahn interact across events, view sentiment trends, and discover connected entities.
Open Dashboard